Open Access

LGALS4 inhibits glycolysis and promotes apoptosis of colorectal cancer cells via β‑catenin signaling

  • Authors:
    • Shengjie Li
    • Kaifeng Yang
    • Jiayou Ye
    • Chengfan Xu
    • Zhixiang Qin
    • Ying Chen
    • Lanjian Yu
    • Tianyu Zhou
    • Bin Sun
    • Jun Xu
  • View Affiliations

  • Published online on: January 7, 2025     https://doi.org/10.3892/ol.2025.14873
  • Article Number: 126
  • Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Colorectal cancer (CRC) is one of the leading causes of cancer‑related deaths worldwide. Glycolysis serves a crucial role in the development of CRC. The aim of the present study was to investigate the function of lectin galactoside‑binding soluble 4 (LGALS4) in the regulation of glycolysis and its therapeutic potential in CRC. In the present study, 175 overlapping differentially expressed genes were identified by comprehensive analysis of The Cancer Genome Atlas database and the GSE26571 CRC dataset from the Gene Expression Omnibus database. LGALS4 was identified as the central gene by prognostic analysis using the mimetic map construction method and least absolute shrinkage and selection operator Cox regression. In vitro experiments were performed to evaluate the effects of LGALS4 overexpression on CRC cell phenotype and aerobic glycolysis, as well as its relationship with β‑catenin signaling. LGALS4 was significantly downregulated in CRC, with an average 3‑fold decrease compared with LGALS4 expression levels in normal tissues. LGALS4 was also significantly associated with patient survival. LGALS4 overexpression inhibited CRC cell growth, induced cell cycle arrest and enhanced 5‑fluorouracil (5‑FU)‑induced apoptosis. Specifically, LGALS4 overexpression resulted in a ~50% decrease in cell proliferation and a ~2‑fold increase in apoptosis. In addition, LGALS4 overexpression inhibited aerobic glycolysis and reduced glucose‑dependent and glycolytic activity in CRC cells. The downregulatory effect of LGALS4 on glycolysis‑related genes was further enhanced by the addition of the β‑catenin inhibitor XAV‑939. LGALS4 expression decreased CRC progression by inhibiting glycolysis and affecting β‑catenin signaling. Overexpression of LGALS4 reduced the proliferation and glycolytic capacity of CRC cells and also enhanced their sensitivity to 5‑FU. These results may potentially provide new perspectives for CRC treatment and targets for future clinical intervention strategies.
View Figures
View References

Related Articles

Journal Cover

March-2025
Volume 29 Issue 3

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Li S, Yang K, Ye J, Xu C, Qin Z, Chen Y, Yu L, Zhou T, Sun B, Xu J, Xu J, et al: <em>LGALS4</em> inhibits glycolysis and promotes apoptosis of colorectal cancer cells via &beta;‑catenin signaling. Oncol Lett 29: 126, 2025.
APA
Li, S., Yang, K., Ye, J., Xu, C., Qin, Z., Chen, Y. ... Xu, J. (2025). <em>LGALS4</em> inhibits glycolysis and promotes apoptosis of colorectal cancer cells via &beta;‑catenin signaling. Oncology Letters, 29, 126. https://doi.org/10.3892/ol.2025.14873
MLA
Li, S., Yang, K., Ye, J., Xu, C., Qin, Z., Chen, Y., Yu, L., Zhou, T., Sun, B., Xu, J."<em>LGALS4</em> inhibits glycolysis and promotes apoptosis of colorectal cancer cells via &beta;‑catenin signaling". Oncology Letters 29.3 (2025): 126.
Chicago
Li, S., Yang, K., Ye, J., Xu, C., Qin, Z., Chen, Y., Yu, L., Zhou, T., Sun, B., Xu, J."<em>LGALS4</em> inhibits glycolysis and promotes apoptosis of colorectal cancer cells via &beta;‑catenin signaling". Oncology Letters 29, no. 3 (2025): 126. https://doi.org/10.3892/ol.2025.14873